Alvileen Diggs

Alvileen Diggs

Auto-generated profile, based on publicly available information

Alvileen Diggs

Daiichi Sankyo, Inc. 211, Mt. Airy Rd., Basking Ridge, NJ07920, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2022 in Future Oncology
Verified
Journal Article
Open access
CDCharles Dharmani
Charles Dharmani
EWEric Wang
Eric Wang
MSMaribel Salas
Maribel Salas
CMColleen McCabe
Colleen McCabe
ADAlvileen Diggs
Alvileen Diggs
VKVicki L Keedy
Vicki L Keedy
For drugs with enhanced serious safety risks, Risk Evaluation and Mitigation Strategy (REMS) may be required. Pexidartinib is approved for treatment of adult symptomatic tenosynovial giant cell tum... Plain language summary For drugs with serious side effects, specific safety measures may be put in place to manage these serious side effects in the form of Risk Evaluation and Mitigation Strategy ...